‘We’ve always been an acquisitions company’: Ebos CEO on firm's future

‘We’ve always been an acquisitions company’: Ebos CEO on firm's future
Ebos CEO John Cullity is looking to other areas after losing the Chemist Warehouse contract. (Image: NZME)
Ella Somers
Ebos is looking to expand as it faces up to life without its $2 billion Chemist Warehouse contract.Although Ebos’ chief executive says the healthcare wholesaler doesn’t give forecasts, there’s one thing he’s certain will remain constant: Ebos will continue to be an acquisitions company.“That's been in the company's DNA even before I joined,” John Cullity told BusinessDesk on Wednesday after the company’s full-year results were released.Cullity has been Ebos’ CEO since 2018 and before...

More Markets

Bathurst vs Talley's: battling on
Markets Part 3

Bathurst vs Talley's: battling on

Bathurst turned back to Asian investors to raise capital this year.

Kiwibank's $500m capital hike fails to inspire
Markets

Kiwibank's $500m capital hike fails to inspire

Capital raise plans designed to help the bank grab market share from its Aussie rivals.

NZX falls as Synlait and Mainfreight take hits
Markets Market Close

NZX falls as Synlait and Mainfreight take hits

Market reacts strongly to news of "challenges" at Synlait's Dunsandel plant.

Tom Raynel 30 Jul 2025
'Slow and disappointing' start to the year for Mainfreight
Markets

'Slow and disappointing' start to the year for Mainfreight

The freight and logistics firm said profits were down across its three main divisions.

Staff reporters 30 Jul 2025